• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to the Editor: "Development and validation of a novel metabolic signature for predicting prognosis in patients with laryngeal cancer".

作者信息

Luo Meng-Si

机构信息

Department of Anesthesiology, Zhongshan Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Chinese Medicine, 3 Kangxin Road, Zhongshan, 528400, Guangdong, China.

出版信息

Eur Arch Otorhinolaryngol. 2021 Sep;278(9):3583-3584. doi: 10.1007/s00405-020-06524-4. Epub 2021 Feb 17.

DOI:10.1007/s00405-020-06524-4
PMID:33598730
Abstract
摘要

相似文献

1
Letter to the Editor: "Development and validation of a novel metabolic signature for predicting prognosis in patients with laryngeal cancer".致编辑的信：“一种用于预测喉癌患者预后的新型代谢特征的开发与验证”
Eur Arch Otorhinolaryngol. 2021 Sep;278(9):3583-3584. doi: 10.1007/s00405-020-06524-4. Epub 2021 Feb 17.
2
Development and validation of a novel metabolic signature for predicting prognosis in patients with laryngeal cancer.
Eur Arch Otorhinolaryngol. 2021 Sep;278(9):3585. doi: 10.1007/s00405-021-06984-2. Epub 2021 Jul 9.
3
Identification and potential mechanisms of a 4-lncRNA signature that predicts prognosis in patients with laryngeal cancer.识别和潜在机制的 4-lncRNA 特征，预测喉癌患者的预后。
Hum Genomics. 2019 Aug 15;13(1):36. doi: 10.1186/s40246-019-0230-6.
4
Letter to the editor "prognostic scores in laryngeal cancer".
Eur Arch Otorhinolaryngol. 2022 Dec;279(12):5963-5964. doi: 10.1007/s00405-022-07331-9. Epub 2022 Mar 7.
5
Letter to the editor "Tumor volume as a prognostic factor of locally advanced laryngeal cancer".致编辑的信《肿瘤体积作为局部晚期喉癌的预后因素》
Eur Arch Otorhinolaryngol. 2021 May;278(5):1705-1706. doi: 10.1007/s00405-020-06523-5. Epub 2021 Jan 9.
6
Exploration and validation of the effects of robust co-expressed immune-related genes on immune infiltration patterns and prognosis in laryngeal cancer.探索和验证稳健共表达的免疫相关基因对喉癌免疫浸润模式和预后的影响。
Int Immunopharmacol. 2020 Aug;85:106622. doi: 10.1016/j.intimp.2020.106622. Epub 2020 May 30.
7
An integrated mRNA-lncRNA signature for relapse prediction in laryngeal cancer.基于 mRNA-lncRNA 的综合特征signature 预测喉癌的复发。
J Cell Biochem. 2019 Sep;120(9):15883-15890. doi: 10.1002/jcb.28859. Epub 2019 May 6.
8
Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma.开发和验证用于预测喉鳞状细胞癌患者生存的表观遗传特征。
DNA Cell Biol. 2021 Feb;40(2):247-264. doi: 10.1089/dna.2020.5789. Epub 2021 Jan 21.
9
Reply to Letter to the Editor: Identification of MSC‑AS1, a novel lncRNA for the diagnosis of laryngeal cancer.
Eur Arch Otorhinolaryngol. 2021 Sep;278(9):3591-3592. doi: 10.1007/s00405-021-06988-y. Epub 2021 Jul 10.
10
Laryngeal Squamous Cell Carcinoma: Potential Molecular Mechanism and Prognostic Signature Based on Immune-Related Genes.喉鳞状细胞癌：基于免疫相关基因的潜在分子机制及预后特征
Med Sci Monit. 2020 Dec 26;26:e928185. doi: 10.12659/MSM.928185.

本文引用的文献

1
Development and validation of a novel metabolic signature for predicting prognosis in patients with laryngeal cancer.开发并验证一种新的代谢标志物，用于预测喉癌患者的预后。
Eur Arch Otorhinolaryngol. 2021 Apr;278(4):1129-1138. doi: 10.1007/s00405-020-06444-3. Epub 2020 Oct 27.